Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Quality of screening with conventional Pap smear in Austria – a longitudinal evaluation

Authors: Éva Rásky, Peter Regitnig, Michél Schenouda, Nathalie Burkert, Wolfgang Freidl

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

In recent decades, the incidence of cervical cancer and cervical cancer mortality in Austria has declined by varying degrees. The Pap smear is to be considered a causal factor for this decline.

Methods

This longitudinal analysis is based on a data set of Pap smear assessments collected by the Committee for Quality Assurance of the Austrian Society of Cytology. Data from 15 laboratories participating in a voluntary self-monitoring program was analyzed for the time span 2004–2008. The data was analyzed in terms of smear quality and assessment quality.
A rank-correlation-test for a monotonic trend analysis in the proportion of the three parameters Pap 0, “satisfactory, but limited/SBL”, and Pap IIID/IV for the timespan 2004 to 2008 was carried out.

Results

For this study, we analyzed an average number of 730,000 smears per year over a five-year period. Specimens from all but two laboratories, i.e. < 2% of all smears, met the quality criterion for Pap 0 (Bethesda 2001 equivalent: Specimen processed and examined, but unsatisfactory for evaluation of epithelial abnormality), whilst only four laboratories, i.e. < 10% of all smears, reached the national requirement for smears classified as “satisfactory, but limited/SBL”.
When using the Pap IIID/IV ratio (LSIL: HSIL/AIS ratio) of 3:1 to 8:1 as a surrogate quality marker for the interpretation of smears, only five laboratories met this criterion during the survey period.
The trend analysis indicated only that an increasing number of samples per year is correlated with an increased proportion of Pap 0 and “satisfactory, but limited/SBL” smears.

Conclusions

Although participants get regular feedback about their results, no general improvements in smear taking or assessment were observed over the years, so mandatory quality management, including the possibility of sanctions, is suggested in order to reduce adverse health effects for women.
Appendix
Available only for authorised users
Literature
1.
go back to reference Zielonke N: Krebsinzidenz und Krebsmortalität in Österreich. 2010, Vienna: Statistics Austria, 65-67. Zielonke N: Krebsinzidenz und Krebsmortalität in Österreich. 2010, Vienna: Statistics Austria, 65-67.
2.
go back to reference Statistics Austria: Krebserkrankungen. 2012, Vienna: Statistics Austria, http://www.statistik.at/web_de/statistiken/gesundheit/krebserkrankungen/gebaermutterhals/index.html; accessed 28th October 2013 Statistics Austria: Krebserkrankungen. 2012, Vienna: Statistics Austria, http://​www.​statistik.​at/​web_​de/​statistiken/​gesundheit/​krebserkrankunge​n/​gebaermutterhals​/​index.​html; accessed 28th October 2013
3.
go back to reference Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011, 378: 1461-1484. 10.1016/S0140-6736(11)61351-2.CrossRefPubMed Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M: Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet. 2011, 378: 1461-1484. 10.1016/S0140-6736(11)61351-2.CrossRefPubMed
4.
go back to reference BMG / Federal Ministry of Health: Österreichischer Impfplan. 2013, Vienna: BMG, http://bmg.gv.at/cms/home/attachments/3/3/6/CH1100/CMS1327680589121/impfplan2013.pdf; accessed 3th July 2013 BMG / Federal Ministry of Health: Österreichischer Impfplan. 2013, Vienna: BMG, http://​bmg.​gv.​at/​cms/​home/​attachments/​3/​3/​6/​CH1100/​CMS1327680589121​/​impfplan2013.​pdf; accessed 3th July 2013
5.
go back to reference USPSTF / US Preventive Services Task Force: Guide to clinical preventive services. 1996, Washington DC: US Department of Health and Human Services USPSTF / US Preventive Services Task Force: Guide to clinical preventive services. 1996, Washington DC: US Department of Health and Human Services
6.
go back to reference Breitenecker G, Wiener H, Stani J: Cervical cancer screening in Austria. Eur J Cancer. 2000, 36: 2189-2190. 10.1016/S0959-8049(00)00322-1.CrossRefPubMed Breitenecker G, Wiener H, Stani J: Cervical cancer screening in Austria. Eur J Cancer. 2000, 36: 2189-2190. 10.1016/S0959-8049(00)00322-1.CrossRefPubMed
7.
go back to reference Wiener HG, Rásky É, Horvat R: Description of the national situation of cervical cancer – Austria. Eur J Cancer. 2009, 45: 2686- Wiener HG, Rásky É, Horvat R: Description of the national situation of cervical cancer – Austria. Eur J Cancer. 2009, 45: 2686-
8.
go back to reference Breitenecker G, Dinges HP, Regitnig P, Wiener H, Vutuc C: Cytopathology in Austria. Cytopathology. 2004, 15: 113-118. 10.1111/j.1365-2303.2004.00125.x.CrossRefPubMed Breitenecker G, Dinges HP, Regitnig P, Wiener H, Vutuc C: Cytopathology in Austria. Cytopathology. 2004, 15: 113-118. 10.1111/j.1365-2303.2004.00125.x.CrossRefPubMed
9.
go back to reference European Commission / EC: European guidelines for quality assurance in mammography screening. 2006, Luxembourg: EC European Commission / EC: European guidelines for quality assurance in mammography screening. 2006, Luxembourg: EC
10.
go back to reference European Commission / EC: European guidelines for quality assurance in cervical screening. 2008, Luxembourg: EC European Commission / EC: European guidelines for quality assurance in cervical screening. 2008, Luxembourg: EC
11.
go back to reference European Commission / EC: European guidelines for quality assurance in colorectal cancer screening and diagnosis. 2011, Luxembourg: EC European Commission / EC: European guidelines for quality assurance in colorectal cancer screening and diagnosis. 2011, Luxembourg: EC
12.
go back to reference European Parliament: Resolution of 10 April 2008 on combating cancer in the enlarged European Union, P6_TA(2008)0121. 2008, Brussels: EU, http://www.europarl.europa.eu/sides/getDoc.do?type=TA&reference=P6-TA-2008-0121&format=XML&language=EN; accessed 28th October 2013, April on combating cancer in the enlarged European Union, P6_TA(2008)0121 European Parliament: Resolution of 10 April 2008 on combating cancer in the enlarged European Union, P6_TA(2008)0121. 2008, Brussels: EU, http://​www.​europarl.​europa.​eu/​sides/​getDoc.​do?​type=​TA&​reference=​P6-TA-2008-0121&​format=​XML&​language=​EN; accessed 28th October 2013, April on combating cancer in the enlarged European Union, P6_TA(2008)0121
13.
go back to reference European Commission / EC: Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. 2008, Luxembourg: EC European Commission / EC: Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. 2008, Luxembourg: EC
14.
go back to reference Breitenecker G, Dinges HP, Regitnig P: Zervixzytologische Nomenklatur und Befundwiedergabe – Neue Leitlinie der Österreichischen Gesellschaft für Zytologie. Gyn-aktiv. 2006, 4: 36-37. http://www.cytology.at/pdf/Leitlinien_Nomenklatur.pdf; accessed 16th Oct 2013 Breitenecker G, Dinges HP, Regitnig P: Zervixzytologische Nomenklatur und Befundwiedergabe – Neue Leitlinie der Österreichischen Gesellschaft für Zytologie. Gyn-aktiv. 2006, 4: 36-37. http://​www.​cytology.​at/​pdf/​Leitlinien_​Nomenklatur.​pdf; accessed 16th Oct 2013
15.
go back to reference Regitnig P, Breitenecker G, Dinges HP, et al: Leitlinie zur Qualität in der gynäkologischen Zytologie. ARGE Qualitätssicherung der Österreichischen Gesellschaft für Zytologie und Österreichische Gesellschaft für Pathologie. 2013, http://www.cytology.at/pdf/20130401_OEGZ_OEGP_Leitlinie_zur_Qualitaet_in_der_gynaekologischen_Zytologie_2013.pdf; accessed 3th July 2013 Regitnig P, Breitenecker G, Dinges HP, et al: Leitlinie zur Qualität in der gynäkologischen Zytologie. ARGE Qualitätssicherung der Österreichischen Gesellschaft für Zytologie und Österreichische Gesellschaft für Pathologie. 2013, http://​www.​cytology.​at/​pdf/​20130401_​OEGZ_​OEGP_​Leitlinie_​zur_​Qualitaet_​in_​der_​gynaekologischen​_​Zytologie_​2013.​pdf; accessed 3th July 2013
16.
go back to reference Dinges HP, Regitnig P, Ropp E, Fladerer H, Moinfar F, Breitenecker G: Früherkennung des Zervixkarzinoms: das Kärntner Qualitätssicherungsprogramm Ergebnisse der Nachkontrolle gynäkologisch-zytologischer Abstriche von Patientinnen mit invasiven Zervixkarzinomen. Frauenarzt. 2006, 47: 724-729. Dinges HP, Regitnig P, Ropp E, Fladerer H, Moinfar F, Breitenecker G: Früherkennung des Zervixkarzinoms: das Kärntner Qualitätssicherungsprogramm Ergebnisse der Nachkontrolle gynäkologisch-zytologischer Abstriche von Patientinnen mit invasiven Zervixkarzinomen. Frauenarzt. 2006, 47: 724-729.
17.
go back to reference Rásky É: Report “Qualitätsoffensive PAP-Abstrich”, by contract for the Association of Social Insurance Providers. 2007, Vienna: HSV Rásky É: Report “Qualitätsoffensive PAP-Abstrich”, by contract for the Association of Social Insurance Providers. 2007, Vienna: HSV
18.
go back to reference Regitnig P, Dinges HP, Ropp E, Fladerer H, Moinfar F, Breitenecker G: Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society of Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health. Pathologe. 2007, 28 (5): 339-345. 10.1007/s00292-007-0931-9.CrossRefPubMed Regitnig P, Dinges HP, Ropp E, Fladerer H, Moinfar F, Breitenecker G: Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society of Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health. Pathologe. 2007, 28 (5): 339-345. 10.1007/s00292-007-0931-9.CrossRefPubMed
19.
go back to reference Regitnig P, Wilfing C: WGKK Projekt zur PAP-Abstrich-Optimierung. 2008, Vienna: WGKK Regitnig P, Wilfing C: WGKK Projekt zur PAP-Abstrich-Optimierung. 2008, Vienna: WGKK
20.
go back to reference Regitnig P, Nader A, Wiener H: Quality of conventional Pap smears. Quality assessment and motivation for improvement. Pathologe. 2012, 33 (4): 293-300. 10.1007/s00292-012-1574-z.CrossRefPubMed Regitnig P, Nader A, Wiener H: Quality of conventional Pap smears. Quality assessment and motivation for improvement. Pathologe. 2012, 33 (4): 293-300. 10.1007/s00292-012-1574-z.CrossRefPubMed
21.
go back to reference ÖGZ / Österreichische Gesellschaft für Zytologie: Jahresbericht. 2010 ÖGZ / Österreichische Gesellschaft für Zytologie: Jahresbericht. 2010
22.
go back to reference Reiner-Concin A: Der PAP-Abstrich. Österreichische Ärztezeitung. 2011, 7: 26-38. Reiner-Concin A: Der PAP-Abstrich. Österreichische Ärztezeitung. 2011, 7: 26-38.
23.
go back to reference Petry KU, Breugelmann JG, Bénard S, Lamure E, Littlewood KJ, Hillemanns P: Cost of screening and treatment of cervical dyscaryosis in Germany. Eur J Gynaecol Oncol. 2008, 29 (4): 345-349.PubMed Petry KU, Breugelmann JG, Bénard S, Lamure E, Littlewood KJ, Hillemanns P: Cost of screening and treatment of cervical dyscaryosis in Germany. Eur J Gynaecol Oncol. 2008, 29 (4): 345-349.PubMed
24.
go back to reference Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ: The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health. 2006, 16 (2): 185-92.CrossRefPubMed Siebert U, Sroczynski G, Hillemanns P, Engel J, Stabenow R, Stegmaier C, Voigt K, Gibis B, Hölzel D, Goldie SJ: The German Cervical Cancer Screening Model: development and validation of a decision-analytic model for cervical cancer screening in Germany. Eur J Public Health. 2006, 16 (2): 185-92.CrossRefPubMed
25.
go back to reference Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Sibert U: Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a desicion analysis. Eur J Cancer. 2011, 47: 1633-1646. 10.1016/j.ejca.2011.03.006.CrossRefPubMed Sroczynski G, Schnell-Inderst P, Mühlberger N, Lang K, Aidelsburger P, Wasem J, Mittendorf T, Engel J, Hillemanns P, Petry KU, Krämer A, Sibert U: Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a desicion analysis. Eur J Cancer. 2011, 47: 1633-1646. 10.1016/j.ejca.2011.03.006.CrossRefPubMed
26.
go back to reference Mühlhauser I, Filz M: Screening auf Zervixkarzinom. arznei-telegramm. 2008, 3: 1-38. Mühlhauser I, Filz M: Screening auf Zervixkarzinom. arznei-telegramm. 2008, 3: 1-38.
27.
go back to reference Bortz J, Lienert GA, Böhnke K: Verteilungsfreie Methoden in der Biostatistik. 1990, Berlin, Heidelberg: Springer VerlagCrossRef Bortz J, Lienert GA, Böhnke K: Verteilungsfreie Methoden in der Biostatistik. 1990, Berlin, Heidelberg: Springer VerlagCrossRef
28.
go back to reference Hedges LV, Vevea JL: Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998, 3: 486-504.CrossRef Hedges LV, Vevea JL: Fixed- and random-effects models in meta-analysis. Psychol Methods. 1998, 3: 486-504.CrossRef
29.
go back to reference Statistics Austria: Bevölkerung nach Geschlecht. 2013, Vienna: Statistics Austria, http://www.statistik.at/web_de/statistiken/bevoelkerung/bevoelkerungsstruktur/bevoelkerung_nach_alter_geschlecht/index.html; accessed 3th July 2013 Statistics Austria: Bevölkerung nach Geschlecht. 2013, Vienna: Statistics Austria, http://​www.​statistik.​at/​web_​de/​statistiken/​bevoelkerung/​bevoelkerungsstr​uktur/​bevoelkerung_​nach_​alter_​geschlecht/​index.​html; accessed 3th July 2013
30.
go back to reference Wilkinson EJ: Pap smears and screening for cervical neoplasia. Clin Obstet Gynecol. 1990, 33: 817-825. 10.1097/00003081-199012000-00017.CrossRefPubMed Wilkinson EJ: Pap smears and screening for cervical neoplasia. Clin Obstet Gynecol. 1990, 33: 817-825. 10.1097/00003081-199012000-00017.CrossRefPubMed
31.
go back to reference Stenkvist B, Soderstrom J: Reasons for cervical cancer despite extensive screening. J Med Screen. 1996, 3: 204-207.PubMed Stenkvist B, Soderstrom J: Reasons for cervical cancer despite extensive screening. J Med Screen. 1996, 3: 204-207.PubMed
32.
go back to reference McCrory D, Matchar D, Bastian L, Datta S, Hasselblad V, Hickey J, Myers E, Nanda K: Evaluation of cervical cytology. Evid Rep Technol Assess (Summ). 1999, 5: 1-6. McCrory D, Matchar D, Bastian L, Datta S, Hasselblad V, Hickey J, Myers E, Nanda K: Evaluation of cervical cytology. Evid Rep Technol Assess (Summ). 1999, 5: 1-6.
33.
go back to reference Canfell K, Barnabas R, Patnick J, Beral V: The predicted effect of changes in cervical screening practice in the UK: results from a modeling study. Br J Cancer. 2004, 91 (3): 530-536. 10.1038/sj.bjc.6602002.CrossRefPubMedPubMedCentral Canfell K, Barnabas R, Patnick J, Beral V: The predicted effect of changes in cervical screening practice in the UK: results from a modeling study. Br J Cancer. 2004, 91 (3): 530-536. 10.1038/sj.bjc.6602002.CrossRefPubMedPubMedCentral
34.
go back to reference Creighton P, Lew JB, Clements M, Smith M, Howard K, Dyer S, Lord S, Canfell K: Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health. 2010, 10: 734-10.1186/1471-2458-10-734. doi:10.1186/1471-2458-10-734CrossRefPubMedPubMedCentral Creighton P, Lew JB, Clements M, Smith M, Howard K, Dyer S, Lord S, Canfell K: Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years. BMC Public Health. 2010, 10: 734-10.1186/1471-2458-10-734. doi:10.1186/1471-2458-10-734CrossRefPubMedPubMedCentral
35.
go back to reference Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J: Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006, 24 (Suppl 3): 78-89.CrossRef Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J: Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine. 2006, 24 (Suppl 3): 78-89.CrossRef
Metadata
Title
Quality of screening with conventional Pap smear in Austria – a longitudinal evaluation
Authors
Éva Rásky
Peter Regitnig
Michél Schenouda
Nathalie Burkert
Wolfgang Freidl
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-998

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue